Cargando…
A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer
PURPOSE: To report a rare case of lattice corneal dystrophy type 1 (LCD1) with bilateral Mooren's ulcer. OBSERVATIONS: This case involved a 62-year-old male patient with LCD1 who presented with the primary complaint of experiencing pain and photophobia in both eyes for 2 months prior to his ini...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883143/ https://www.ncbi.nlm.nih.gov/pubmed/36718435 http://dx.doi.org/10.1016/j.ajoc.2023.101796 |
_version_ | 1784879443454459904 |
---|---|
author | Kayukawa, Kanae Kitazawa, Koji Wakimasu, Koichi Sotozono, Chie Kinoshita, Shigeru |
author_facet | Kayukawa, Kanae Kitazawa, Koji Wakimasu, Koichi Sotozono, Chie Kinoshita, Shigeru |
author_sort | Kayukawa, Kanae |
collection | PubMed |
description | PURPOSE: To report a rare case of lattice corneal dystrophy type 1 (LCD1) with bilateral Mooren's ulcer. OBSERVATIONS: This case involved a 62-year-old male patient with LCD1 who presented with the primary complaint of experiencing pain and photophobia in both eyes for 2 months prior to his initial visit. Upon examination, a peripheral corneal ulcer was observed in both eyes covering more than 3 of the 4 quadrants, accompanied with ciliary injection and severe corneal infiltration. He was diagnosed with Mooren's ulcer, and treatment with 0.1% betamethasone and 0.5% levofloxacin eye drops and systemic cyclosporine and betamethasone was initiated. At 1-month post treatment initiation, a remaining ulceration ridge was observed on the corneal surface in his left eye, which was subsequently resected. Complete epithelialization was achieved at 1-month postoperative in the left eye and after 6-months of conservative topical treatment in the right eye. At 8–9 years post onset of Mooren's ulcer, the patient underwent penetrating keratoplasty in both eyes while undergoing treatment with oral cyclosporine administration for severe corneal opacity due to progression of lattice dystrophy. Post treatment, there has been no recurrence of ulcerations, even though more that 10 years has passed since the onset of Mooren's ulcer. CONCLUSIONS AND IMPORTANCE: To the best of our knowledge, this is the first reported case of LCD1 with bilateral Mooren's ulcer, and in this rare case, the patient was successfully treated with a combination of steroid, cyclosporine, and peripheral superficial keratectomy, and a good visual outcome was achieved after penetrating keratoplasty (PK) under the use of systemic cyclosporine. |
format | Online Article Text |
id | pubmed-9883143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-98831432023-01-29 A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer Kayukawa, Kanae Kitazawa, Koji Wakimasu, Koichi Sotozono, Chie Kinoshita, Shigeru Am J Ophthalmol Case Rep Case Report PURPOSE: To report a rare case of lattice corneal dystrophy type 1 (LCD1) with bilateral Mooren's ulcer. OBSERVATIONS: This case involved a 62-year-old male patient with LCD1 who presented with the primary complaint of experiencing pain and photophobia in both eyes for 2 months prior to his initial visit. Upon examination, a peripheral corneal ulcer was observed in both eyes covering more than 3 of the 4 quadrants, accompanied with ciliary injection and severe corneal infiltration. He was diagnosed with Mooren's ulcer, and treatment with 0.1% betamethasone and 0.5% levofloxacin eye drops and systemic cyclosporine and betamethasone was initiated. At 1-month post treatment initiation, a remaining ulceration ridge was observed on the corneal surface in his left eye, which was subsequently resected. Complete epithelialization was achieved at 1-month postoperative in the left eye and after 6-months of conservative topical treatment in the right eye. At 8–9 years post onset of Mooren's ulcer, the patient underwent penetrating keratoplasty in both eyes while undergoing treatment with oral cyclosporine administration for severe corneal opacity due to progression of lattice dystrophy. Post treatment, there has been no recurrence of ulcerations, even though more that 10 years has passed since the onset of Mooren's ulcer. CONCLUSIONS AND IMPORTANCE: To the best of our knowledge, this is the first reported case of LCD1 with bilateral Mooren's ulcer, and in this rare case, the patient was successfully treated with a combination of steroid, cyclosporine, and peripheral superficial keratectomy, and a good visual outcome was achieved after penetrating keratoplasty (PK) under the use of systemic cyclosporine. Elsevier 2023-01-12 /pmc/articles/PMC9883143/ /pubmed/36718435 http://dx.doi.org/10.1016/j.ajoc.2023.101796 Text en © 2023 Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Kayukawa, Kanae Kitazawa, Koji Wakimasu, Koichi Sotozono, Chie Kinoshita, Shigeru A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer |
title | A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer |
title_full | A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer |
title_fullStr | A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer |
title_full_unstemmed | A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer |
title_short | A case of lattice corneal dystrophy type 1 with bilateral Mooren's ulcer |
title_sort | case of lattice corneal dystrophy type 1 with bilateral mooren's ulcer |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883143/ https://www.ncbi.nlm.nih.gov/pubmed/36718435 http://dx.doi.org/10.1016/j.ajoc.2023.101796 |
work_keys_str_mv | AT kayukawakanae acaseoflatticecornealdystrophytype1withbilateralmoorensulcer AT kitazawakoji acaseoflatticecornealdystrophytype1withbilateralmoorensulcer AT wakimasukoichi acaseoflatticecornealdystrophytype1withbilateralmoorensulcer AT sotozonochie acaseoflatticecornealdystrophytype1withbilateralmoorensulcer AT kinoshitashigeru acaseoflatticecornealdystrophytype1withbilateralmoorensulcer AT kayukawakanae caseoflatticecornealdystrophytype1withbilateralmoorensulcer AT kitazawakoji caseoflatticecornealdystrophytype1withbilateralmoorensulcer AT wakimasukoichi caseoflatticecornealdystrophytype1withbilateralmoorensulcer AT sotozonochie caseoflatticecornealdystrophytype1withbilateralmoorensulcer AT kinoshitashigeru caseoflatticecornealdystrophytype1withbilateralmoorensulcer |